Table 1.

Prostaglandin (PGE₂) production in PC-3 medium, after different treatments. Values (means ± SEM) are from three independent experiments (n = 3). ANOVA was used to compare PGE2 production in all experimental conditions. * p < 0.01 vs. control cells.

PC-3 Treatment	PGE2 (pg/mL)
CTRL	103.1 ± 9.2
GO (10 µg/mL)	64.5 ± 6.3 *
GO (12 µg/mL)	66.3 ± 6.0 *
GO (30 µg/mL)	60.2 ± 4.8 *
Tetra(HPRG)-Fam (2 µM)	78.1 ± 6.2 *
Tetra(HPRG)-Fam (4 µM)	71.7 ± 6.4 *
Tetra(HPRG)-Fam (6 µM)	76.3 ± 5.8 *
GO_A@T ([GO] = 10 µg/mL, [Tetra(HPRG)-Fam] = 2 µM	40.5 ± 3.7 *
GO_B@T ([GO] = 12 µg/mL, [Tetra(HPRG)-Fam] = 4 µM	44.3 ± 4.1 *
GO_A@T ([GO] = 30 µg/mL, [Tetra(HPRG)-Fam] = 6 µM	41.1 ± 4.8 *
GO_A+T ([GO] = 10 µg/mL, [Tetra(HPRG)-Fam] = 2 µM	62.2 ± 6.1 *
GO_B+T ([GO] = 12 µg/mL, [Tetra(HPRG)-Fam] = 4 µM	66.0 ± 5.5 *
GO_A+T ([GO] = 30 µg/mL, [Tetra(HPRG)-Fam] = 6 µM	57.8 ± 6.4 *